Literature DB >> 33757451

Incidence of antidepressant use among community dwellers with and without Parkinson's disease - a nationwide cohort study.

Eerik Hentilä1,2, Miia Tiihonen1,2, Heidi Taipale1,2,3,4, Sirpa Hartikainen1,2, Anna-Maija Tolppanen5,6.   

Abstract

BACKGROUND: Antidepressant use is more common in people with Parkinson's disease (PD), but it is unknown when this difference emerges.
METHODS: We studied the incidence of antidepressant use in six-month periods from 10 years before to 15 years after PD diagnosis in the nationwide register-based Finnish Study on Parkinson's disease (FINPARK). This study included 20,456 community dwellers with clinically verified PD diagnosed during 1996-2015 and 140,291 matched comparison persons.
RESULTS: Altogether 44.3% of people with PD initiated antidepressants, compared to 25.0% of people without PD. The difference was largest 6 months before PD diagnosis (incidence rate ratio 5.28, 95% CI 4.80-5.80; 9.02 and 1.68 initiations/100 person-years in people with and without PD, respectively). The difference emerged already 7 years before the diagnosis and remained above the comparison group for most of the study period.
CONCLUSIONS: Persons with PD may have symptoms that require antidepressant treatment years before and after diagnosis. The symptoms needing antidepressant treatment may be clinical signs of possible PD and they should be considered as a need to assess clinical status in person diagnosed with PD.

Entities:  

Keywords:  Antidepressant; Cohort studies; Epidemiology; Incidence; Parkinson’s disease

Year:  2021        PMID: 33757451      PMCID: PMC7986562          DOI: 10.1186/s12877-021-02145-6

Source DB:  PubMed          Journal:  BMC Geriatr        ISSN: 1471-2318            Impact factor:   3.921


  20 in total

Review 1.  Depression and Parkinson's disease: a review.

Authors:  J L Cummings
Journal:  Am J Psychiatry       Date:  1992-04       Impact factor: 18.112

Review 2.  Epidemiology of Parkinson's disease.

Authors:  Ole-Bjørn Tysnes; Anette Storstein
Journal:  J Neural Transm (Vienna)       Date:  2017-02-01       Impact factor: 3.575

3.  Dissociating apathy and depression in Parkinson disease.

Authors:  L Kirsch-Darrow; H H Fernandez; H F Fernandez; M Marsiske; M S Okun; D Bowers
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

4.  Non-motor features of Parkinson disease.

Authors:  Anthony H V Schapira; K Ray Chaudhuri; Peter Jenner
Journal:  Nat Rev Neurosci       Date:  2017-07-13       Impact factor: 34.870

Review 5.  A systematic review of prevalence studies of depression in Parkinson's disease.

Authors:  Jennifer S A M Reijnders; Uwe Ehrt; Wim E J Weber; Dag Aarsland; Albert F G Leentjens
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

6.  Parkinson's disease and antidepressant drug treatment: a case-register study.

Authors:  Mette Brandt-Christensen; Ana Garcia Lopez; Flemming Mørkeberg Nilsson; Per Kragh Andersen; Lars Vedel Kessing
Journal:  Parkinsonism Relat Disord       Date:  2007-03-21       Impact factor: 4.891

7.  Use of antidepressants in Parkinson's disease: A Swedish register-based study of over 1.5 million older people.

Authors:  Ylva Haasum; Johan Fastbom; Kristina Johnell
Journal:  Parkinsonism Relat Disord       Date:  2016-04-19       Impact factor: 4.891

Review 8.  Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis.

Authors:  Giovanni Rizzo; Massimiliano Copetti; Simona Arcuti; Davide Martino; Andrea Fontana; Giancarlo Logroscino
Journal:  Neurology       Date:  2016-01-13       Impact factor: 9.910

9.  Prediagnostic presentations of Parkinson's disease in primary care: a case-control study.

Authors:  Anette Schrag; Laura Horsfall; Kate Walters; Alastair Noyce; Irene Petersen
Journal:  Lancet Neurol       Date:  2014-11-27       Impact factor: 44.182

Review 10.  Meta-analysis of early nonmotor features and risk factors for Parkinson disease.

Authors:  Alastair J Noyce; Jonathan P Bestwick; Laura Silveira-Moriyama; Christopher H Hawkes; Gavin Giovannoni; Andrew J Lees; Anette Schrag
Journal:  Ann Neurol       Date:  2012-10-15       Impact factor: 10.422

View more
  2 in total

1.  Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetes.

Authors:  Katriina Sunnarborg; Miia Tiihonen; Marjo Huovinen; Marjaana Koponen; Sirpa Hartikainen; Anna-Maija Tolppanen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2022-05-11       Impact factor: 2.732

2.  Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid Arthritis.

Authors:  Anne Paakinaho; Marjaana Koponen; Miia Tiihonen; Markku Kauppi; Sirpa Hartikainen; Anna-Maija Tolppanen
Journal:  Neurology       Date:  2022-01-21       Impact factor: 9.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.